Published Special Issue
Volume 3, Issue 1-4
Expired Date:
Nov. 30, 2014
Order the Hard Copy
share
Special Issues
Expand the Popularity of Your Conference
Publish conference papers as a Special Issue
Send your Special Issue proposal to:
review_specialissue@sciencepg.com
Submit Hot Topics
Submit
If you wish to order hard copies, please click here to know more information.
Home / Journals / American Journal of Life Sciences / Pharmacogenomics & Personalized Medicine
Pharmacogenomics & Personalized Medicine
Lead Guest Editor:
Professor Wei Zhang
Institute of Clinical Pharmacology, Xiangya Hospital, Central south university, Hunan, China
Guest Editors
Yan Shu
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland
Baltimore, USA
Shengying Qin
Biophysiqe Laboratory Department of Nuclear Medicine, Faculty of Medicine, Cadi Ayyad University
Shanghai, China
Paper List
1
Authors: Zhiying Luo, Fazhong He, Jianquan Luo, Wei Zhang
Pages: 1-6 Published Online: Nov. 24, 2014
Views 2702 Downloads 132
2
Authors: Zhiying Luo, Xi Li, Mouze Liu, Yan Shu, Jiye Yin, Xiaoping Chen, Jianquan Luo, Xiaobing Li, Wei Zhang
Pages: 7-13 Published Online: Dec. 27, 2014
Views 2794 Downloads 120
3
Authors: Shan Cao, Gan Zhou, Yao Chen, Dong Guo, Zhi-rong Tan, Lan Fan, Hai-tang Hu, Xiang-hong Qin, Hong-hao Zhou, Dong-sheng Ouyang, Wei Zhang
Pages: 14-20 Published Online: Jan. 27, 2015
Views 3035 Downloads 105
Introduction
Pharmacogenomics is the study of the role of genetics in drug disposition and response. Pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Such approaches promise the advent of "personalized medicine"; in which drugs and drug combinations are optimized for each individual's unique genetic makeup. It’s the future model of life science and health care. Reviews and reports by the researchers are involved in this rapidly developing area. This issue focuses on those aspects:

1. The emergence of new pharmacogenomic initiatives and their impact on R&D and regulatory strategies
2. Emerging technologies for accessing and exploiting genomic information
3. Reviews of genotyping and clinical data in particular therapeutic areas
4. Development of novel diagnostic products and strategies
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186